Document

We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-251308) and Form S-8 (No. 333-164376) of Cumberland Pharmaceuticals Inc. of our report dated March 20, 2020, (except for the effects of presenting discontinued operations discussed in Note 19, as to which the date is December 10, 2020), relating to the consolidated financial statements and schedule, which appears in this Form 10-K.